News
If Neuroendocrine Cancer Has Spread, Why Would Surgery Still Be Considered?
By Anna C. Greene, PhD, NETRF Chief Scientific Officer When someone is diagnosed with metastatic neuroendocrine cancer, one of the most confusing questions can be:
You Ask, NETRF Answers: Is Neuroendocrine Carcinoma Different From a Neuroendocrine Tumor?
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Patients often hear similar-sounding terms: neuroendocrine tumor, neuroendocrine carcinoma, NET, NEC, high-grade, poorly differentiated, well-differentiated. It
Updates to NETRF’s Board of Scientific Advisors
NETRF BOSA Leadership Transition The Neuroendocrine Tumor Research Foundation is pleased to share updates on the leadership and membership of its Board of Scientific Advisors
Thrivership: Moving Beyond Survival to a Life of Purpose, Connection, and Growth
By Jessica Thomas, LCSW Director of Patient Education, NETRF For many people living with neuroendocrine cancer, the journey begins with a singular focus: survival. A
What Small Cell Lung Cancer Research Can Teach Us About Neuroendocrine Cancer
By Anna C. Greene, PhD | NETRF Chief Scientific Officer In May, I attended the 2026 Small Cell Lung Cancer Consortium hosted by the National
You Ask, NETRF Answers: What Happens After PRRT?
Research-informed answers to your most important questions about neuroendocrine cancer. By Anna C. Greene, PhD, NETRF Chief Scientific Officer You asked. We’re answering. Through the
Grewal Research Update: Neuroendocrine Cancer Research at ASCO 2026
By Udhayvir Singh Grewal, MD GI/Neuroendocrine Medical Oncologist and Assistant Professor of Medical Oncology, Winship Cancer Institute of Emory University School of Medicine Dr. Grewal contributed
Seeing the Invisible: How Tiny “Tumorlets” Could Change Our Understanding of Small Intestinal Neuroendocrine Tumors
By Anna C. Greene, PhD, NETRF Chief Scientific Officer At the Neuroendocrine Tumor Research Foundation (NETRF), we fund research that can change how neuroendocrine cancers
NETRF Launches First Early Detection Research Funding Opportunity
Neuroendocrine neoplasms (NENs) can be difficult to detect, and many patients face long delays before receiving an accurate diagnosis. In many cases, NENs are not
Where Thrivership Meets Cancer Research: A Patient Perspective
By Carrie Camino, Member, NETRF Board of Directors Last month I had the extraordinary opportunity to attend the American Association of Cancer Research (AACR) as